US Patent 10966922 Pharmaceutical formulations
Patent 10966922 was granted and assigned to Auspex Pharmaceuticals, Inc. on April, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+155 characters)
Article
Patent abstract
The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109669220
Date of Patent
April 6, 2021
0Patent Application Number
165102460
Date Filed
July 12, 2019
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109669220
Date of Patent
April 6, 2021
0Patent Application Number
165102460
Date Filed
July 12, 2019
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 10966922 Pharmaceutical formulations
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10966922
Date of patent
April 6, 2021
Patent application number
16510246
Date Filed
July 12, 2019
Patent citations
Patent primary examiner
Find more entities like US Patent 10966922 Pharmaceutical formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
